Multiple Assemblies exist for SMTL entry 5nvz
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetylcyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 16); X-RAY DIFFRACTION 2.70 Å

	SMTL ID 5nvz.1 Ligands (2~{S},4~{R})-1-[(2~{S})-2-[(1-ethanoylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Elongin-B; Elongin-C; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 5nvz.2 Ligands (2~{S},4~{R})-1-[(2~{S})-2-[(1-ethanoylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Elongin-B; Elongin-C; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 5nvz.3 Ligands (2~{S},4~{R})-1-[(2~{S})-2-[(1-ethanoylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Elongin-B; Elongin-C; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 5nvz.4 Ligands (2~{S},4~{R})-1-[(2~{S})-2-[(1-ethanoylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide Polypeptides Elongin-B; Elongin-C; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer